New England Peptide appoints CEO and CFO
Martina Diekmann has previously held several global management positions with leading, world-class CDMOs, including the Bachem Group and Solvias AG.
Ms. Diekmann holds a Ph.D. in Pharmaceutical Chemistry from the University of Bonn, Germany.
David Gavlik has 25 years of experience in all aspects of financial management and a track record of successful integration and consolidation of add on acquisitions, which he gained as Vice President of Finance from Comark and Lista International. ■